Business UpdateJun 2, 2026, 08:33 AM
Neuronetics to Present Real-World TMS Data at CTMSS Annual Meeting
AI Summary
Neuronetics, Inc. announced its participation as a Silver Sponsor at the 2026 Clinical TMS Society (CTMSS) Annual Meeting. The company will present real-world data from its proprietary TrakStar database in an oral presentation and multiple scientific posters, focusing on advancing the understanding of transcranial magnetic stimulation (TMS) for mental health conditions. This involvement underscores Neuronetics' commitment to innovation, scientific leadership, and expanding evidence-based treatment options. Additionally, Neuronetics will demonstrate NeuroStar's navigation capabilities at the PULSES Course.
Key Highlights
- Neuronetics is a Silver Sponsor at the 2026 Clinical TMS Society (CTMSS) Annual Meeting.
- Company to present real-world data from its proprietary TrakStar database.
- Data will be featured in an oral presentation and multiple scientific posters.
- Presentations include TMS effectiveness for MDD, adolescent outcomes, and maintenance therapy.
- Neuronetics will demonstrate NeuroStar's navigation at the PULSES Course.
- Participation highlights commitment to advancing TMS research and evidence-based treatments.
Price Impact
More from STIM